tau phosphorylation drug
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| apoE | regulates | tau phosphorylation | — | 1 |
| apoE4 | regulates | tau phosphorylation | — | 1 |
| APOE ε4 | risk_factor_for | tau phosphorylation | — | 1 |
| tau phosphorylation | associated_with | Alzheimer's disease | — | 1 |
| tau phosphorylation | expressed_in | medial ganglionic eminence | — | 1 |
| tau phosphorylation | biomarker_for | phosphorylated tau | — | 1 |
Mentioned in (9)
Papers in which this entity is mentioned.
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- Epigenetics in Alzheimer's Disease. (2022)
- Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease. (2021)
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. (2018)
- ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease. (2017)
- Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations. (2017)
- New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. (2014)
- Physical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases? (2014)
- ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice. (2013)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| tau phosphorylation | phenotype | 8 | 19 |
| at8 | drug | 2 | 3 |
| phf1 | drug | 2 | 2 |
| tau phosphorylation | drug | — | — |